Polyzois Makras is consultant endocrinologist, Director of the Endocrinology Department, the Department of Medical Research, and of the National expert center for Langerhans Cell Histiocytosis (LCH) and Erdheim Chester Disease (ECD) of251 Hellenic Air Force &VA General Hospital of Athens, Greece. He received his MD from the University of Thessaloniki, Greece in 1994, and he was trained in Internal Medicine and Endocrinology in Athens. He received his PhD Degree from the University of Thrace, Greece, and he served as a clinical fellow at the Department of Endocrinology and Metabolic Diseases of the Leiden University Medical Center, The Netherlands between 2006-2007.
During the last eighteen years he has been engaged in research in disorders of calcium and bone metabolism as well as inrare diseases (mainly LCH and other non-langerhans histiocytoses). He co-founded the LCH adult clinic in 2005 which became the National expert center for LCH and ECD in 2019 and joined the ERN – EuroBloodNet in 2022.
He is a founding member of the European Consortium for Histiocytosis (ECHO) and founder and head of the Adult ECHO working group.
He is former President of the Hellenic Society for the Study of Bone Metabolism, and member of the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) since 2020. He established the first fracture liaison service (FLS)in Greece, and he is the leading author of all diagnostic and therapeutic guidelines for osteoporosis and parathyroid disorders in the same country during the last 13 years.